The Oligonucleotide Therapeutics Society aims to foster academia and industry-based research and development of oligonucleotide therapeutics. The society envisions a new era of oligonucleotide drugs that vastly impacts therapeutic modalities, much like antibodies have revolutionized human therapeutics.
The OTS Awards for Science Outreach and Patient Advocacy were established to honor individuals contributing significantly towards scientific knowledge dissemination or patient advocacy in the context of oligonucleotide research and development. These awards aim to provide trustworthy information to the public, ensure access to expert knowledge, and amplify patient voices. Recipients are recognized for their outstanding efforts in these domains and receive a $500 USD award, a certificate, complimentary registration to the OTS Annual Meeting, a featured profile on OTS social media, and the option to present a webinar.